CLPT Key Statistics, Chart & Performance
The current stock price of CLPT is 14.4 USD. In the past month the price decreased by -43.44%. In the past year, price increased by 16.41%.
CLPT Latest News, Press Relases and Analysis
CLPT Competitors/Peers
Symbol | Company Name | TA | FA | PE | Market Cap |
|---|---|---|---|---|---|
| ABT | ABBOTT LABORATORIES | 25.49 | 221.37B | ||
| ISRG | INTUITIVE SURGICAL INC | 66.03 | 203.79B | ||
| BSX | BOSTON SCIENTIFIC CORP | 33.23 | 145.27B | ||
| SYK | STRYKER CORP | 28.11 | 141.54B | ||
| IDXX | IDEXX LABORATORIES INC | 59.65 | 60.17B | ||
| BDX | BECTON DICKINSON AND CO | 13.24 | 54.73B | ||
| EW | EDWARDS LIFESCIENCES CORP | 32.96 | 49.16B | ||
| RMD | RESMED INC | 25.31 | 36.56B | ||
| GEHC | GE HEALTHCARE TECHNOLOGY | 17.05 | 35.64B | ||
| DXCM | DEXCOM INC | 33.45 | 24.40B | ||
| PODD | INSULET CORP | 73.86 | 23.75B | ||
| ZBH | ZIMMER BIOMET HOLDINGS INC | 11.56 | 18.53B |
Related stock screener links
About CLPT
Company Profile
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 115 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The firm is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The firm also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
Company Info
CLEARPOINT NEURO INC
120 S. Sierra Avenue, Suite 100
Solana Beach CALIFORNIA 92618 US
CEO: Joseph M. Burnett
Employees: 115
Phone: 19499006833
CLEARPOINT NEURO INC / CLPT FAQ
What does CLPT do?
Clearpoint Neuro, Inc. engages in the development and commercialization of platforms for performing minimally invasive surgical procedures in the brain and heart. The company is headquartered in Solana Beach, California and currently employs 115 full-time employees. The company went IPO on 2019-07-03. The firm provides both clinical products as well as pre-clinical development services for controlled drug and device delivery. Its flagship product is the ClearPoint Neuro Navigation System. The firm is engaged with healthcare and research centers in North America, Europe, Asia, and South America. Its primary medical device product, the ClearPoint system, is an integrated system comprised of hardware components, disposable components, and intuitive, menu-driven software. Its ClearPoint Prism Neuro Laser Therapy System is indicated for use to necrotize or coagulate soft tissue through interstitial irradiation or thermal therapy for neuro applications under 3.0T magnetic resonance imaging (MRI) guidance. The firm also provides solutions for direct CNS delivery of therapeutics in preclinical studies and clinical trials worldwide.
What is the current price of CLPT stock?
The current stock price of CLPT is 14.4 USD. The price increased by 4.2% in the last trading session.
Does CLPT stock pay dividends?
CLPT does not pay a dividend.
What is the ChartMill rating of CLEARPOINT NEURO INC stock?
CLPT has a ChartMill Technical rating of 3 out of 10 and a ChartMill Fundamental rating of 3 out of 10.
Should I buy CLPT stock?
This depends on your investment goals. Check the Technical and Fundamental Analysis tabs for insights on CLPT.
What is the employee count for CLPT stock?
CLEARPOINT NEURO INC (CLPT) currently has 115 employees.
Can you provide the upcoming earnings date for CLEARPOINT NEURO INC?
CLEARPOINT NEURO INC (CLPT) will report earnings on 2026-02-24, after the market close.
CLPT Technical Analysis
ChartMill assigns a technical rating of 3 / 10 to CLPT. When comparing the yearly performance of all stocks, CLPT is one of the better performing stocks in the market, outperforming 89.57% of all stocks.
CLPT Fundamental Analysis
ChartMill assigns a fundamental rating of 3 / 10 to CLPT. The financial health of CLPT is average, but there are quite some concerns on its profitability.
CLPT Financial Highlights
Over the last trailing twelve months CLPT reported a non-GAAP Earnings per Share(EPS) of -0.84. The EPS decreased by -21.74% compared to the year before.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PM (TTM) | N/A | ||
| ROA | -35.35% | ||
| ROE | -112.56% | ||
| Debt/Equity | 1.46 |
CLPT Forecast & Estimates
8 analysts have analysed CLPT and the average price target is 29.58 USD. This implies a price increase of 105.42% is expected in the next year compared to the current price of 14.4.
For the next year, analysts expect an EPS growth of -17.3% and a revenue growth 18.26% for CLPT